Delayed viral clearance of chronic hepatitis C in patients after treatment failure.

Hepatitis C virus (HCV) infection usually progresses to chronic hepatitis, with rare cases of spontaneous viral eradication. We present herein four cases involving patients that were initially declared to have failed to respond to treatments, based on the presence of HCV RNA that was still detectable after completion of the standard treatment for chronic hepatitis C with genotype 2. However, the HCV RNA became undetectable, with a delayed response, after discontinuation of therapy. Two of the four patients were diagnosed as treatment failures after extended treatment, and the other two received no further treatment after the standard treatment. All four patients maintained a sustained virological response during the periodic follow-up after delayed viral clearance.

[1]  P. Gaglio.  Treatment of chronic hepatitis C in a slow responder: a case for extended therapy , 2009, Nature Reviews Gastroenterology &Hepatology.

[2]  L. Jeng,et al.  Persistent transaminase elevations in chronic hepatitis C patients with virological response during peginterferon and ribavirin therapy. , 2009, Hepato-gastroenterology.

[3]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[4]  T. Berg,et al.  Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3 , 2008, Antiviral therapy.

[5]  M. Rizzetto,et al.  Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C , 2007 .

[6]  S. Han,et al.  Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment. , 2007, Gut and liver.

[7]  T. Asselah,et al.  Chronic Hepatitis C: Viral Clearance Several Months after Discontinuation of Therapy in Two Non-responders , 2007, Infection.

[8]  B. Annicchiarico,et al.  A 5‐year prospective study of the late resolution of chronic hepatitis C after antiviral therapy , 2007, Alimentary pharmacology & therapeutics.

[9]  M. Rizzetto,et al.  Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C. , 2007, Annals of the New York Academy of Sciences.

[10]  V. Balan,et al.  Pegylated Interferon and Ribavirin Failures: Is Retreatment an Option? , 2007, Digestive Diseases and Sciences.

[11]  M. Manns,et al.  Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C , 2003, Hepatology.

[12]  B. Walker,et al.  Spontaneous resolution of chronic hepatitis C virus disease after withdrawal of immunosuppression. , 2003, Gastroenterology.

[13]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[14]  S. Giampaoli,et al.  Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population , 2002, Gut.

[15]  C. O. Zein,et al.  Spontaneous clearance of chronic hepatitis C during pregnancy , 2001, American Journal of Gastroenterology.

[16]  H. Yoshiji,et al.  Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C , 2001, American Journal of Gastroenterology.

[17]  O. Yokosuka,et al.  Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years. , 1999, Journal of hepatology.

[18]  G. Ramadori,et al.  Clearance of HCV RNA in a chronic hepatitis C virus-infected patient during acute hepatitis B virus superinfection. , 1999, Liver.

[19]  F. Lunel,et al.  Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. , 1999, The Journal of infectious diseases.